These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31080710)

  • 1. Different toenail onychomycosis due to
    Ge G; Li D; Mei H; Lu G; Zheng H; Liu W; Shi D
    Med Mycol Case Rep; 2019 Jun; 24():69-71. PubMed ID: 31080710
    [No Abstract]   [Full Text] [Related]  

  • 2. Onychomycosis with greenish-black discolorations and recurrent onycholysis caused by
    Ge G; Yang Z; Li D; Sybren de Hoog G; Shi D
    Med Mycol Case Rep; 2019 Jun; 24():48-50. PubMed ID: 31024790
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification, antifungal susceptibility and scanning electron microscopy of a keratinolytic strain of Rhodotorula mucilaginosa: a primary causative agent of onychomycosis.
    da Cunha MM; dos Santos LP; Dornelas-Ribeiro M; Vermelho AB; Rozental S
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):396-403. PubMed ID: 19170752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.
    De Doncker P; Decroix J; Piérard GE; Roelant D; Woestenborghs R; Jacqmin P; Odds F; Heremans A; Dockx P; Roseeuw D
    Arch Dermatol; 1996 Jan; 132(1):34-41. PubMed ID: 8546481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Survival and Resistance of Rhodotorula mucilaginosa Following Inhibition of Pigment Production by Naftifine.
    Idris NFB; Jia Q; Lu H; Guo Y; Wang Y; Hao R; Tu Z
    Curr Microbiol; 2023 Jul; 80(9):285. PubMed ID: 37452917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole.
    Khosravi AR; Mansouri P
    Mycopathologia; 2001; 150(1):9-13. PubMed ID: 11392568
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Pârvu M; Moţ CA; Pârvu AE; Mircea C; Stoeber L; Roşca-Casian O; Ţigu AB
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of Candida parapsilosis in onychomycosis. An epidemiological survey in Israel.
    Segal R; Kimchi A; Kritzman A; Inbar R; Segal Z
    Mycoses; 2000 Oct; 43(9-10):349-53. PubMed ID: 11105538
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kukhar Y; Smagulova A; Daniyarova A; Baiduissenova A; Kiyan V
    J Fungi (Basel); 2020 Nov; 6(4):. PubMed ID: 33255642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].
    Manzano-Gayosso P; Méndez-Tovar LJ; Arenas R; Hernández-Hernández F; Millán-Chiu B; Torres-Rodríguez JM; Cortés-González E; Fernández R; López-Martínez R
    Rev Iberoam Micol; 2011; 28(1):32-5. PubMed ID: 21147249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis.
    Fich F; Abarzúa-Araya A; Pérez M; Nauhm Y; León E
    Indian J Dermatol; 2014 Jan; 59(1):24-9. PubMed ID: 24470656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifth toenail clinical response to systemic antifungal therapy is not a marker of successful therapy for other toenails with onychomycosis.
    Avner S; Nir N; Henri T
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1194-6. PubMed ID: 17062030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nail psoriasis masqueraded by secondary infection with Rhodotorula mucilaginosa.
    Martini K; Müller H; Huemer HP; Höpfl R
    Mycoses; 2013 Nov; 56(6):690-2. PubMed ID: 23691938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case of Mixed Infection of Toenail Caused by
    Salvador A; Veiga FF; Svidzinski TIE; Negri M
    J Fungi (Basel); 2023 May; 9(5):. PubMed ID: 37233292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of 0.9-ms 1064-nm Nd:YAG laser combined with itraconazole for treatment of toenail onychomycosis].
    Zhong ZM; Yang YM; Zhou ST; Hu YX; Mao ZH; Wu Z; Han X; Liu KX; Hunag SY; Hu YQ; Lu Y; Zhou XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):358-362. PubMed ID: 29643045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible naftifine-induced carotenoid depigmentation in Rhodotorula mucilaginosa (A. Jörg.) F.C. Harrison causing onychomycosis.
    Moț AC; Pârvu M; Pârvu AE; Roşca-Casian O; Dina NE; Leopold N; Silaghi-Dumitrescu R; Mircea C
    Sci Rep; 2017 Sep; 7(1):11125. PubMed ID: 28894295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model.
    Marchetti A; Piech CT; McGhan WF; Neugut AI; Smith BT
    Clin Ther; 1996; 18(4):757-77; discussion 702. PubMed ID: 8879902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis.
    Firooz A; Khamesipour A; Dowlati Y
    J Dermatolog Treat; 2003 Jun; 14(2):95-8. PubMed ID: 12775316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China.
    Feng X; Ling B; Yang X; Liao W; Pan W; Yao Z
    Mycopathologia; 2015 Dec; 180(5-6):365-71. PubMed ID: 26227864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.